Symptom Management

The other morning, one of my Google alerts for “multiple sclerosis” popped up with a headline that stopped me mid-scroll: “Global Study Finds Fewer People Progressing to Secondary Progressive MS.” 

Naturally, I clicked.

I’ve lived with MS for 20 years, so any time I see the words progression and slowing in the same sentence, I pay attention. The article summarized new research published in “Frontiers in Neurology,” which suggested that fewer people are transitioning to secondary progressive MS than in past decades. You can read the study yourself here.

As I read through the findings, I started thinking about what this means for those of us living with MS every day. I remember when I was first diagnosed in the early 2000s. At that time, the focus was mostly on treating relapses and trying to delay the inevitable decline that many of us feared. “Slowing progression” sounded like wishful thinking, not a realistic goal.

Fast forward two decades, and the landscape looks completely different. There are now more than 20 disease-modifying therapies available, including oral and infusion options that didn’t exist when I started this journey. Neurologists can diagnose MS earlier and start treatment sooner, which seems to make a real difference in keeping symptoms stable.

For me, the most encouraging part of the study wasn’t the numbers. It was the validation that stability counts as success. So many of us measure progress by what we lose: a skill, an ability, a little piece of independence. But what if the real story is about what we keep? Maybe maintaining our current level of function, year after year, is something worth celebrating.

Reading that article also reminded me that while medication plays a huge role, it’s not the only factor. Consistency, rest, stress management, nutrition, and connection with others living with MS all matter too. We can’t control everything about this disease, but we can control how we respond to it, and that’s powerful.

After finishing the piece, I sat back and thought about how far the MS community has come. When I was first diagnosed, the conversations were full of fear and uncertainty. Today, they’re filled with words like hope, control, and possibility. That shift in mindset is as important as the science itself.

If you’re reading this and wondering what these new findings might mean for you, consider bringing it up at your next neurology appointment. Ask your doctor what they’ve heard about MS progression and how current treatments can help maintain your stability. It’s a conversation worth having.

For me, that’s what this research represents, not just data points, but direction. A sign that the path we’re on is leading somewhere brighter.